CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer-Reference-Cited by-同舟云学术

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

Published:2018-09-10 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Slagter Astrid E.,Jansen Edwin P. M.,van Laarhoven Hanneke W. M.,van Sandick Johanna W.,van Grieken Nicole C. T.,Sikorska Karolina,Cats Annemieke,Muller-Timmermans Pietje,Hulshof Maarten C. C. M.,Boot Henk,Los Maartje,Beerepoot Laurens V.,Peters Frank P. J.,Hospers Geke A. P.,van Etten Boudewijn,Hartgrink Henk H.,van Berge Henegouwen Mark I.,Nieuwenhuijzen Grard A. P.,van Hillegersberg Richard,van der Peet Donald L.,Grabsch Heike I.,Verheij Marcel

Funder

KWF Kankerbestrijding

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4770-2.pdf

Reference59 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.

2. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol. 2014;15(1):23–34.

3. Msika S, Benhamiche AM, Jouve J-L, Rat P, Faivre J. Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer. 2000;36:390–6. https://doi.org/10.1016/S0959-8049(99)00308-1 .